Product NDC: | 0023-4385 |
Proprietary Name: | BETAGAN |
Non Proprietary Name: | levobunolol hydrochloride |
Active Ingredient(s): | 5 mg/mL & nbsp; levobunolol hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0023-4385 |
Labeler Name: | Allergan, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019219 |
Marketing Category: | NDA |
Start Marketing Date: | 19860724 |
Package NDC: | 0023-4385-15 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (0023-4385-15) > 15 mL in 1 BOTTLE, DROPPER |
NDC Code | 0023-4385-15 |
Proprietary Name | BETAGAN |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (0023-4385-15) > 15 mL in 1 BOTTLE, DROPPER |
Product NDC | 0023-4385 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levobunolol hydrochloride |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 19860724 |
Marketing Category Name | NDA |
Labeler Name | Allergan, Inc. |
Substance Name | LEVOBUNOLOL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |